|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
| If recently published figures are to be believed the pharmaceutical industry in Europe and European consumers are under an ever-increasing threat from counterfeit products, portends Philip Payne, RSSL Pharma
According to the European Commission, seizures of counterfeit pharmaceuticals in Europe rose five-fold in 2006 compared with 2005, with a huge proportion of the counterfeits emerging from the rapidly expanding, but less regulated economies of India and China. Indeed, the EC claims that India, the United Arab Emirates and China account for over 80 per cent of the fake medicines entering Europe. Similarly, the World Health Organization (WHO) has concluded that the majority of counterfeits are produced within developing countries, and a recent report from WHO indicates that India is responsible for about 35 per cent of the world’s fake drugs. The same report puts the value of the illicit trade at approximately $200 million.
Whilst most countries recognise intellectual property rights and patents, and therefore recognise counterfeits as illegal, it is clear that some jurisdictions are not totally committed to enforcing their own regulations. Others do not even consider counterfeiting as a crime. Political corruption has often been a driving force for poor regulation, which in some cases encourages counterfeiting, or at the very least provides no deterrent. There is no doubt that some ‘businessmen’ have discovered that the counterfeiting of medicines is lucrative and relatively low risk, and there is even anecdotal evidence that a few companies may be producing legitimate goods at one end of the factory and counterfeits at the other.
If organised criminals have been ready to seize the opportunity to create great profits for themselves, it is partly down to the industry’s failure to plug the gaps in its own systems and to recognise the areas in which it is most vulnerable. One thing that characterises virtually every criminal activity is that the criminal chooses the easiest route to make his money, according to how much he hopes to gain. It is comparable to the fact that the petty thief is more likely to snatch a purse left exposed on a supermarket trolley than attempt to pick the pocket of a shopper. |
Read full article >>
|
 |
 |
 |
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
 |

 |
Industry Events |
 |
EMBALLAGE 2008. World Packaging Exhibition
16-21 November 2008, Paris-Nord Villepinte - France
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
|